ASCENDIS PHARMA A/S — Credit Rating and Financial Key Figures

ASCENDIS PHARMA A/S (CVR number: 29918791K) is a company from GENTOFTE. The company reported a net sales of 266.7 mEUR in 2023, demonstrating a growth of 421.2 % compared to the previous year. The operating profit percentage was poor at -170.8 % (EBIT: -455.5 mEUR), while net earnings were -481.4 mEUR. The profitability of the company measured by Return on Assets (ROA) was -41.7 %, which can be considered poor and Return on Equity (ROE) was -88.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -15 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. ASCENDIS PHARMA A/S's liquidity measured by quick ratio was 2.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.